Table 2.
Oncological Outcomes of patients undergoing laparoscopy.
Name | 3Y DFS * (%) | 3Y OS ° (%) | 5Y DFS * (%) | 5Y OS ° (%) |
---|---|---|---|---|
Colomer 2008 [8] | 95 | 100 | / | / |
Ditto 2016 [28] | 90 | 95 | 83 | 95 |
Facer 2019 [21] | / | / | / | 86.4 |
Gallotta 2016 [29] | 89 | 92 | / | / |
Gallotta 2021 [22] | / | / | 83 | 93.8 |
Ghezzi 2011 [23] | 91.2 | 97 | / | / |
Koo 2014 [30] | 86.1 | / | 86.1 | / |
Lee 2017 [24] | / | 95 | / | 95 |
Liu 2013 [31] | / | 97.1 | / | / |
Lu 2016 [32] | / | 100 | 91.3 | 92.9 |
Melamed 2016 [33] | / | 94.1 | / | / |
Merlier 2020 [34] | 93 | 97.3 | 88 | 97.3 |
Minig 2016 [35] | 87 | 98 | 84 | 98 |
Muzii 2008 [25] | 95.6 | 100 | / | / |
Nezhat 2008 [10] | 91.6 | 100 | / | / |
Park 2018 [11] | 100 | 100 | / | / |
Tozzi 2003 [26] | 91.6 | 100 | / | / |
Wu 2009 [36] | / | / | 69.5 | 67.4 |
* Disease Free Survival. ° Overall Survival.